Disease-Modifying Antirheumatic Drugs (DMARD)
- PMID: 29939640
- Bookshelf ID: NBK507863
Disease-Modifying Antirheumatic Drugs (DMARD)
Excerpt
Disease-modifying antirheumatic drugs (DMARDs) are a class of drugs indicated for the treatment of several inflammatory arthritides, including rheumatoid arthritis (RA), as well as for the management of other connective tissue diseases and some cancers. This activity will highlight the mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of DMARDs, pertinent for members of the interprofessional team in the treatment of patients with autoimmune disorders that will respond to such therapy.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, Aslani S. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019 Jul;234(7):10018-10031. - PubMed
-
- Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 2018 Oct 02;320(13):1360-1372. - PubMed
-
- Wang W, Zhou H, Liu L. Side effects of methotrexate therapy for rheumatoid arthritis: A systematic review. Eur J Med Chem. 2018 Oct 05;158:502-516. - PubMed
Publication types
LinkOut - more resources
Full Text Sources